News Focus
News Focus
icon url

mblimon

03/13/07 11:11 AM

#3027 RE: DB9 #3025

Re-GTC Biotherapeutics Grants EXPANDED License to PharmAthene for Further Development of Protexia(R)

Who knows this has been Ashley Lawton's first contribution to GTCB. I feel much better, now that I know that GTCB's Intellectual Property will not be given away like they have given away major part of the first 100 million shares.